4
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Clinical Progress in Neuroblastoma

&
Pages 644-653 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yu-Guo Yuan, Yan-Hong Wang, Hui-Hui Xing & Sangiliyandi Gurunathan. (2017) Quercetin-mediated synthesis of graphene oxide–silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma. International Journal of Nanomedicine 12, pages 5819-5839.
Read now

Articles from other publishers (6)

Ayca Tas, Burak Tüzün, Ali N. Khalilov, Parham Taslimi, Tugba Ağbektas & Nese Keklikcioglu Cakmak. (2023) In vitro cytotoxic effects, in silico studies, some metabolic enzymes inhibition, and vibrational spectral analysis of novel β-amino alcohol compounds. Journal of Molecular Structure 1273, pages 134282.
Crossref
Rakesh Mishra & Amit Agrawal. 2021. Pheochromocytoma, Paraganglioma and Neuroblastoma. Pheochromocytoma, Paraganglioma and Neuroblastoma.
Lixian Dong, Yihui Liu, Anamaris M. Colberg-Poley, Karen Kaucic & Stephan Ladisch. (2011) Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function. Glycoconjugate Journal 28:3-4, pages 137-147.
Crossref
N Aloui-Kasbi, S Felah, I Bellagha, S Barsaoui & A Hammou. (2004) Le neuroblastome?: apport de l?imagerie. Journal de P?diatrie et de Pu?riculture 17:1, pages 28-33.
Crossref
C Bergeron. (1998) D?pistage du neuroblastome. Journal de P?diatrie et de Pu?riculture 11:5, pages 259-264.
Crossref
Randal K Wada, David S.M Pai, Jerry Huang, Joyce M Yamashiro & Neil Sidell. (1997) Interferon-? and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Letters 121:2, pages 181-188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.